Storage time affects umbilical cord blood viability

Transfusion

Volumn 54, Issue 5, 2014, Pages 1278-1285

  Guttridge, Martin G ^a   Soh, Teck Guan ^a   Belfield, Heli ^a   Sidders, Chris ^a   Watt, Suzanne M ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; CD34 ANTIGEN; CD45 ANTIGEN; LIPOCORTIN 5;

ARTICLE; BLOOD DONOR; BLOOD STORAGE; BLOOD VOLUME; CELL COUNT; CELL POPULATION; CELL VIABILITY; CRYOPRESERVATION; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MONOCYTE; STORAGE TEMPERATURE; UMBILICAL CORD BLOOD;

ANNEXIN A5; ANTIGENS, CD34; ANTIGENS, CD45; BLOOD PRESERVATION; CELL SURVIVAL; CRYOPRESERVATION; DACTINOMYCIN; FETAL BLOOD; HUMANS; TIME FACTORS;

EID: 84900487690     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12481     Document Type: Article

References (38)

1. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anaemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 1989; 321: 1174-1178. (Pubitemid 19255814)
2. Ballen KK, Koreth J, Chen YB, et al. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood 2012; 119: 1972-1980.
3. Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013; 121: 752-758.
4. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
5. Barker J, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leucocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957-2961.
6. Rocha V, Spellman S, Zhang MJ, et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012; 18: 1890-1896.
7. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA identical sibling. N Engl J Med 2000; 342: 1846-1854. (Pubitemid 30419048)
8. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantion after myeloablative conditioning: impact on transplantation outcomes in 110 adults with hematological disease. Blood 2007; 110: 3064-3070. (Pubitemid 350006962)
9. Watt SM,. Umbilical cord blood stem cell banking. In:, Moo-Young M, Butler M, Webb C, et al., editors. Comprehensive biotechnology. 2nd ed. Amsterdam, The Netherlands: Elsevier BV Press; 2011. p. 397-406.
10. Shlebak AA, Marley SB, Roberts IA, et al. Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation. Bone Marrow Transplant 1999; 23: 131-136. (Pubitemid 29048213)
11. Hubel A, Carlquist D, Clay M, et al. Liquid storage, shipment and cryopreservation of cord blood. Transfusion 2004; 44: 518-525. (Pubitemid 38437587)
12. Guttridge MG, Sidders C, Booth-Davey E, et al. Factors affecting volume reduction and red cell depletion of bone marrow on the Cobe Spectra cell separator before haematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 175-181. (Pubitemid 44102944)
13. Kurtz J, Seetharaman S, Greco N, et al. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation. Transfusion 2007; 47: 1578-1587. (Pubitemid 47300601)
14. Lioznov M, Dellbrugger C, Sputtek A Fehse B, et al. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSC, but not BM. Bone Marrow Transplant 2008; 42: 121-128.
15. Hubel A, Carlquist D, Clay M, et al. Cryopreservation of cord blood after liquid storage. Cytotherapy 2003; 5: 370-376. (Pubitemid 37369024)
16. Solomon M, Wofford J, Johnson C, et al. Factors influencing cord blood viability assessment before cryopreservation. Transfusion 2010; 50: 820-830.
17. Guttridge MG, Belfield H, Hollyman D, et al. An internal positive for the enumeration of CD45+ and CD34+ cells by flow cytometry allows monitoring of reagent and operator performance. Cytotherapy 2007; 9: 275-282. (Pubitemid 46705867)
18. Peffault de Latour R, Purtill D, Ruggeri A, et al. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: A study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant 2011; 17: 78-85.
19. Ramirez P, Wagner JE, DeFor TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant 2012; 47: 799-803.
20. Cutler C, Ballen KK,. Improving outcomes in umbilical cord blood transplantation: state of the art. Blood Rev 2012; 26: 241-246.
21. De Alarcon PA, Werner EJ,. Normal values and laboratory methods. In:, De Alarcon PA, Werner EJ, editors. Neonatal hematology. Cambridge: Cambridge University Press; 2005. p. 406-430.
22. Geaghan SM,. Hematologic values and appearances in the healthy fetus, neonate, and child. Clin Lab Med 1999; 19: 1-37. (Pubitemid 29217316)
23. Scaradavou A, Smith KM, Hawke R, et al. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant 2010; 16: 500-508.
24. Stewart DA, Guo D, Luider J, et al. Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose. Bone Marrow Transplant 1999; 23: 1237-1243. (Pubitemid 29312929)
25. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
26. Pecora AL, Preti RA, Gleim GW, et al. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients. J Clin Oncol 1998; 16: 2093-2104. (Pubitemid 28265046)
27. Meldgaard Knudsen L, Jensen L, Jarlbaek L, et al. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation. Haematologica 1999; 84: 517-524. (Pubitemid 29323260)
28. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011; 117: 3277-3285.
29. de Boer F, Dräger AM, Pinedo HM, et al. Extensive early apoptosis in frozen-thawed CD34-positive stem cell decreases threshold doses for haemtatological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 29: 249-255. (Pubitemid 34189518)
30. Schuurhuis GJ, Muijen MM, Oberink JW, et al. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 487-498. (Pubitemid 32266498)
31. Shim JS, Cho B, Kim M, et al. Early apoptosis in CD34+ cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood. Br J Haematol 2006; 135: 210-213. (Pubitemid 44401618)
32. Pope B, Mitsakos K, Bilgin A, et al. Predicting overall viability of cord blood harvests. Transfusion 2012; 52: 1079-1085.
33. Pamphilon D, Curnow E, Belfield H, et al. Storage characteristics of cord blood progenitor cells: report of a multicentre study by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) Collaboration. Transfusion 2011; 51: 1284-1290.
34. Radke TF, Barbosa D, Duggleby RC, et al. The assessment of parameters affecting the quality of cord blood by the applicance of the annexin V staining method and correlation with CFU assays. Stem Cells Int 2013; 2013: 823912.
35. Louis I, Wagner E, Dieng MM, et al. Impact of storage temperature and processing delays on cord blood quality: discrepancy between functional in vitro and in vivo assays. Transfusion 2012; 52: 2401-2405.
36. Fry LJ, Querol S, Gomez SG, et al. Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts. Transfusion 2013; 53: 1834-1842.
37. Pereira-Cunha F, Duarte ASS, Costa FF, et al. Viability of umbilical cord blood mononuclear cell subsets until 96 hours after collection. Transfusion 2013; 53: 2034-2042.
38. Wallet HL, Sobh M, Morisset S, et al. Double umbilical cord blood transplantation for hematological malignancies: A long-term analysis from the SFGM-TC registry. Exp Hematol 2013 Jul 2;pii:S0301-472X(13)00597-3. [Epub ahead of print].